Nasopharyngeal carcinoma (NPC) is a big problem in Southeast Asia and southern China. Many people get it, but it's often found too late. Doctors have been using drugs that target a protein called EGFR to fight it. These drugs work at first, but the cancer cells find ways to resist them. Scientists wanted to know why this happens. They looked at something called Adip...

Nasopharyngeal carcinoma (NPC) is a type of cancer that often involves the Epstein-Barr virus (EBV). This virus can mess with the immune system, making it harder for the body to fight the cancer. A specific type of immune cell, called regulatory T cells (Tregs), plays a big role in how NPC develops and progresses. Tregs help the tumor hide from the immune system, w...

Sarcopenia, muscle loss, can change the outcome of patients with late-stage nasopharyngeal cancer. Using MRI scans before therapy to check the muscle index at the third neck vertebrae, it turns out to be useful. How cool is that! These medical findings help us comprehend why muscle loss matters. Why would bad therapy have an effect on the patient? ? Let's d...

Cancer remains a significant global health concern, with head and neck cancers, like nasopharyngeal carcinoma (NPC), being particularly common in East Asia. Scientists have long known that the Epstein-Barr virus (EBV) DNA load and the systemic immune inflammation (SII) index can help predict how NPC patients will fare. But what happens when you combine these indicato...